Intended for healthcare professionals

Editor's Choice

Are we at risk of being at risk?

BMJ 2010; 341 doi: (Published 02 September 2010) Cite this as: BMJ 2010;341:c4766


As practitioners of modern medicine we owe a lot to
pharmaceuticals for tremendous advances with improved outcomes and
reductions of the burden of disease. Cardiovascular and cancer prevention
and treatment are real success stories with many enjoying considerable
longevity. Risk levels for many chronic diseases are increasingly
recognized to start at levels once thought to be non risk. The onus is on us as
practising physicians not to medicalize these risk levels but to educate
the public and the 'power be' in preventive public health measures. The
key is not to fall prey to the marketing techniques of pharma industry
which is the real culprit. MK JOSE

Competing interests: No competing interests

06 September 2010
mathew k jose
physician & teacher